STOCK TITAN

[Form 4] Integra LifeSciences Holdings Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Mueller Water Products, Inc. (MWA) Form 4 filing dated 07 July 2025 details a small open-market purchase by Director Brian C. Healy.

  • Healy bought 1,110 common shares at a weighted average price of $24.74 per share.
  • The transaction was executed under a Rule 10b5-1 trading plan adopted on 07 Feb 2025, indicating it was pre-arranged and not reactive to non-public information.
  • Following the purchase, the director’s direct beneficial ownership rises to 15,730 shares.
  • No derivative securities were involved and no dispositions were reported.

While the dollar value of the purchase (~$27,500) is modest relative to MWA’s market capitalization, insider buying—particularly by a board member—can be interpreted as a signal of confidence in the company’s outlook. Because the trade was executed pursuant to a preset plan, it reduces concerns about information asymmetry but still represents incremental insider alignment with shareholder interests.

Mueller Water Products, Inc. (MWA) ha presentato il modulo Form 4 il 07 luglio 2025, che riporta un piccolo acquisto sul mercato aperto da parte del Direttore Brian C. Healy.

  • Healy ha acquistato 1.110 azioni ordinarie a un prezzo medio ponderato di 24,74 $ per azione.
  • L’operazione è stata effettuata nell’ambito di un piano di trading Rule 10b5-1 adottato il 07 febbraio 2025, il che indica che era predefinita e non reattiva a informazioni riservate.
  • Dopo l’acquisto, la posizione diretta del direttore sale a 15.730 azioni.
  • Non sono stati coinvolti strumenti derivati né sono state segnalate cessioni.

Pur essendo il valore dell’acquisto (circa 27.500 $) modesto rispetto alla capitalizzazione di mercato di MWA, l’acquisto da parte di un insider, specialmente un membro del consiglio, può essere interpretato come un segnale di fiducia nelle prospettive dell’azienda. Poiché la transazione è stata effettuata secondo un piano prestabilito, riduce le preoccupazioni riguardo a eventuali asimmetrie informative, rappresentando comunque un allineamento incrementale degli interessi dell’insider con quelli degli azionisti.

Mueller Water Products, Inc. (MWA) presentó el formulario Form 4 el 07 de julio de 2025, que detalla una pequeña compra en el mercado abierto realizada por el Director Brian C. Healy.

  • Healy compró 1,110 acciones ordinarias a un precio promedio ponderado de $24.74 por acción.
  • La transacción se ejecutó bajo un plan de negociación Rule 10b5-1 adoptado el 07 de febrero de 2025, lo que indica que fue preestablecida y no reactiva a información no pública.
  • Después de la compra, la posesión directa del director aumenta a 15,730 acciones.
  • No se involucraron valores derivados ni se reportaron disposiciones.

Aunque el valor en dólares de la compra (aproximadamente $27,500) es modesto en relación con la capitalización de mercado de MWA, la compra por parte de un insider, especialmente un miembro de la junta, puede interpretarse como una señal de confianza en las perspectivas de la empresa. Debido a que la operación se ejecutó conforme a un plan preestablecido, reduce preocupaciones sobre asimetrías de información, pero aún representa un alineamiento incremental de los intereses del insider con los de los accionistas.

Mueller Water Products, Inc. (MWA)는 2025년 7월 7일자 Form 4 제출서에서 이사 Brian C. Healy의 소규모 공개시장 매수를 상세히 보고했습니다.

  • Healy는 1,110주 보통주를 주당 $24.74의 가중평균 가격에 매수했습니다.
  • 이 거래는 2025년 2월 7일 채택된 Rule 10b5-1 거래 계획에 따라 실행되었으며, 이는 사전 계획된 거래로 비공개 정보에 따른 반응이 아님을 의미합니다.
  • 매수 후 이사의 직접 보유 주식 수는 15,730주로 증가했습니다.
  • 파생 상품은 포함되지 않았으며, 처분 내역도 보고되지 않았습니다.

매수 금액(약 $27,500)은 MWA 시가총액에 비해 소액이지만, 특히 이사회 구성원의 내부자 매수는 회사 전망에 대한 신뢰의 신호로 해석될 수 있습니다. 거래가 사전에 설정된 계획에 따라 이루어졌기 때문에 정보 비대칭에 대한 우려를 줄이면서도 내부자와 주주 간 이해관계의 점진적 일치를 나타냅니다.

Mueller Water Products, Inc. (MWA) a déposé le formulaire Form 4 daté du 7 juillet 2025, détaillant un petit achat sur le marché ouvert par le directeur Brian C. Healy.

  • Healy a acheté 1 110 actions ordinaires à un prix moyen pondéré de 24,74 $ par action.
  • La transaction a été réalisée dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 7 février 2025, indiquant qu’elle était préétablie et non réactive à des informations non publiques.
  • Après l’achat, la possession directe du directeur s’élève à 15 730 actions.
  • Aucun titre dérivé n’a été impliqué et aucune cession n’a été rapportée.

Bien que la valeur en dollars de l’achat (environ 27 500 $) soit modeste par rapport à la capitalisation boursière de MWA, l’achat par un initié — en particulier un membre du conseil d’administration — peut être interprété comme un signe de confiance dans les perspectives de l’entreprise. Étant donné que la transaction a été effectuée conformément à un plan préétabli, cela réduit les inquiétudes liées à l’asymétrie d’information tout en représentant un alignement progressif des intérêts de l’initié avec ceux des actionnaires.

Mueller Water Products, Inc. (MWA) reichte am 07. Juli 2025 eine Form 4 ein, die einen kleinen Kauf am offenen Markt durch Direktor Brian C. Healy beschreibt.

  • Healy kaufte 1.110 Stammaktien zu einem gewichteten Durchschnittspreis von 24,74 $ pro Aktie.
  • Die Transaktion erfolgte im Rahmen eines Rule 10b5-1 Handelsplans, der am 07. Februar 2025 angenommen wurde, was darauf hinweist, dass der Kauf vorab geplant war und nicht auf nicht-öffentlichen Informationen basierte.
  • Nach dem Kauf steigt der direkte wirtschaftliche Eigentum des Direktors auf 15.730 Aktien.
  • Es wurden keine derivativen Wertpapiere verwendet und keine Verkäufe gemeldet.

Obwohl der Kaufwert (ca. 27.500 $) im Vergleich zur Marktkapitalisierung von MWA gering ist, kann der Insider-Kauf – insbesondere durch ein Vorstandsmitglied – als Vertrauenssignal in die Zukunftsaussichten des Unternehmens gewertet werden. Da der Handel im Rahmen eines vorher festgelegten Plans erfolgte, mindert dies Bedenken hinsichtlich Informationsasymmetrien, stellt jedoch dennoch eine verstärkte Übereinstimmung der Interessen des Insiders mit denen der Aktionäre dar.

Positive
  • Director insider purchase: Brian C. Healy acquired 1,110 shares at $24.74, raising direct holdings to 15,730 shares, a modest but positive confidence signal.
Negative
  • None.

Insights

TL;DR: Minor insider buy; positive sentiment but immaterial to valuation.

The purchase of 1,110 shares adds only a few thousand dollars to Brian Healy’s stake, lifting his holdings to 15,730 shares. Insider buying is generally viewed favorably, yet the size is negligible versus Mueller Water’s average daily volume and total shares outstanding. Because the trade was executed under a Rule 10b5-1 plan, it weakens any timing signal. From a valuation standpoint, the transaction is not impactful; however, it does reinforce board-level confidence and modestly improves governance optics.

TL;DR: Governance-friendly purchase under 10b5-1; signals alignment, low impact.

The director’s pre-planned acquisition under Rule 10b5-1 demonstrates good governance practice by avoiding potential insider-trading concerns. Increasing direct ownership can strengthen board alignment with shareholders, yet the incremental 1,110-share addition is too small to materially change control dynamics. Overall, the event is neutral from a control-risk perspective and only marginally positive for sentiment.

Mueller Water Products, Inc. (MWA) ha presentato il modulo Form 4 il 07 luglio 2025, che riporta un piccolo acquisto sul mercato aperto da parte del Direttore Brian C. Healy.

  • Healy ha acquistato 1.110 azioni ordinarie a un prezzo medio ponderato di 24,74 $ per azione.
  • L’operazione è stata effettuata nell’ambito di un piano di trading Rule 10b5-1 adottato il 07 febbraio 2025, il che indica che era predefinita e non reattiva a informazioni riservate.
  • Dopo l’acquisto, la posizione diretta del direttore sale a 15.730 azioni.
  • Non sono stati coinvolti strumenti derivati né sono state segnalate cessioni.

Pur essendo il valore dell’acquisto (circa 27.500 $) modesto rispetto alla capitalizzazione di mercato di MWA, l’acquisto da parte di un insider, specialmente un membro del consiglio, può essere interpretato come un segnale di fiducia nelle prospettive dell’azienda. Poiché la transazione è stata effettuata secondo un piano prestabilito, riduce le preoccupazioni riguardo a eventuali asimmetrie informative, rappresentando comunque un allineamento incrementale degli interessi dell’insider con quelli degli azionisti.

Mueller Water Products, Inc. (MWA) presentó el formulario Form 4 el 07 de julio de 2025, que detalla una pequeña compra en el mercado abierto realizada por el Director Brian C. Healy.

  • Healy compró 1,110 acciones ordinarias a un precio promedio ponderado de $24.74 por acción.
  • La transacción se ejecutó bajo un plan de negociación Rule 10b5-1 adoptado el 07 de febrero de 2025, lo que indica que fue preestablecida y no reactiva a información no pública.
  • Después de la compra, la posesión directa del director aumenta a 15,730 acciones.
  • No se involucraron valores derivados ni se reportaron disposiciones.

Aunque el valor en dólares de la compra (aproximadamente $27,500) es modesto en relación con la capitalización de mercado de MWA, la compra por parte de un insider, especialmente un miembro de la junta, puede interpretarse como una señal de confianza en las perspectivas de la empresa. Debido a que la operación se ejecutó conforme a un plan preestablecido, reduce preocupaciones sobre asimetrías de información, pero aún representa un alineamiento incremental de los intereses del insider con los de los accionistas.

Mueller Water Products, Inc. (MWA)는 2025년 7월 7일자 Form 4 제출서에서 이사 Brian C. Healy의 소규모 공개시장 매수를 상세히 보고했습니다.

  • Healy는 1,110주 보통주를 주당 $24.74의 가중평균 가격에 매수했습니다.
  • 이 거래는 2025년 2월 7일 채택된 Rule 10b5-1 거래 계획에 따라 실행되었으며, 이는 사전 계획된 거래로 비공개 정보에 따른 반응이 아님을 의미합니다.
  • 매수 후 이사의 직접 보유 주식 수는 15,730주로 증가했습니다.
  • 파생 상품은 포함되지 않았으며, 처분 내역도 보고되지 않았습니다.

매수 금액(약 $27,500)은 MWA 시가총액에 비해 소액이지만, 특히 이사회 구성원의 내부자 매수는 회사 전망에 대한 신뢰의 신호로 해석될 수 있습니다. 거래가 사전에 설정된 계획에 따라 이루어졌기 때문에 정보 비대칭에 대한 우려를 줄이면서도 내부자와 주주 간 이해관계의 점진적 일치를 나타냅니다.

Mueller Water Products, Inc. (MWA) a déposé le formulaire Form 4 daté du 7 juillet 2025, détaillant un petit achat sur le marché ouvert par le directeur Brian C. Healy.

  • Healy a acheté 1 110 actions ordinaires à un prix moyen pondéré de 24,74 $ par action.
  • La transaction a été réalisée dans le cadre d’un plan de négociation Rule 10b5-1 adopté le 7 février 2025, indiquant qu’elle était préétablie et non réactive à des informations non publiques.
  • Après l’achat, la possession directe du directeur s’élève à 15 730 actions.
  • Aucun titre dérivé n’a été impliqué et aucune cession n’a été rapportée.

Bien que la valeur en dollars de l’achat (environ 27 500 $) soit modeste par rapport à la capitalisation boursière de MWA, l’achat par un initié — en particulier un membre du conseil d’administration — peut être interprété comme un signe de confiance dans les perspectives de l’entreprise. Étant donné que la transaction a été effectuée conformément à un plan préétabli, cela réduit les inquiétudes liées à l’asymétrie d’information tout en représentant un alignement progressif des intérêts de l’initié avec ceux des actionnaires.

Mueller Water Products, Inc. (MWA) reichte am 07. Juli 2025 eine Form 4 ein, die einen kleinen Kauf am offenen Markt durch Direktor Brian C. Healy beschreibt.

  • Healy kaufte 1.110 Stammaktien zu einem gewichteten Durchschnittspreis von 24,74 $ pro Aktie.
  • Die Transaktion erfolgte im Rahmen eines Rule 10b5-1 Handelsplans, der am 07. Februar 2025 angenommen wurde, was darauf hinweist, dass der Kauf vorab geplant war und nicht auf nicht-öffentlichen Informationen basierte.
  • Nach dem Kauf steigt der direkte wirtschaftliche Eigentum des Direktors auf 15.730 Aktien.
  • Es wurden keine derivativen Wertpapiere verwendet und keine Verkäufe gemeldet.

Obwohl der Kaufwert (ca. 27.500 $) im Vergleich zur Marktkapitalisierung von MWA gering ist, kann der Insider-Kauf – insbesondere durch ein Vorstandsmitglied – als Vertrauenssignal in die Zukunftsaussichten des Unternehmens gewertet werden. Da der Handel im Rahmen eines vorher festgelegten Plans erfolgte, mindert dies Bedenken hinsichtlich Informationsasymmetrien, stellt jedoch dennoch eine verstärkte Übereinstimmung der Interessen des Insiders mit denen der Aktionäre dar.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mosebrook Jeffrey

(Last) (First) (Middle)
1100 CAMPUS ROAD

(Street)
PRINCETON NJ 08540

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Fin & Princ Acct Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/03/2025 F 3,345 D $13.49 36,600 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Lesha Shinn; Attorney-in-Fact 07/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Mueller Water Products (MWA) shares did Director Brian C. Healy buy?

He purchased 1,110 common shares.

At what price were the MWA shares acquired?

The weighted average purchase price was $24.74 per share.

When did the insider transaction occur?

The trade was executed on 07 July 2025.

What is Brian C. Healy’s total direct ownership after this trade?

His direct beneficial ownership increased to 15,730 shares.

Was the transaction made under a Rule 10b5-1 trading plan?

Yes. The plan was adopted on 07 Feb 2025.

Were any derivative securities involved in this Form 4 filing?

No. The filing lists no derivative securities acquired or disposed.
Integra Lifesciences Hldgs Cp

NASDAQ:IART

IART Rankings

IART Latest News

IART Latest SEC Filings

IART Stock Data

1.05B
66.51M
14.24%
91.53%
5.06%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
PRINCETON